cetylpyridinium chloride anhydrous has been researched along with Familial Combined Hyperlipidemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arner, E; Arner, P; Bernard, S; Buchholz, BA; Eriksson, M; Frayn, KN; Hauner, H; Liebl, J; Possnert, G; Rydén, M; Salehpour, M; Skurk, T; Spalding, KL; Steier, P | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Familial Combined Hyperlipidemia
Article | Year |
---|---|
Dynamics of human adipose lipid turnover in health and metabolic disease.
Topics: Adipocytes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Cell Size; Cellular Senescence; Child; Child, Preschool; Cohort Studies; DNA; Dyslipidemias; Health; Humans; Hyperlipidemia, Familial Combined; Lipid Metabolism; Lipolysis; Metabolic Diseases; Middle Aged; Nuclear Weapons; Obesity; Subcutaneous Fat; Time Factors; Triglycerides; Young Adult | 2011 |